Watson Files FDA Application for Generic Yaz

November 7, 2007

Watson Pharmaceuticals, Inc., a leading specialty pharmaceutical company, confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market a generic version of Yaz tablets prior to the expiration of patents owned by Bayer Schering Pharma AG and Bayer Healthcare Pharmaceuticals Inc. (Bayer).
Yahoo Finance